Cassava Sciences SAVA Stock PRICE PREDICTION! | DETAILED ANALYSIS WHAT'S HAPPENING WITH SAVA Stock?

SAVA Stock Analysis: Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. In this SAVA Stock Analysis video, we discuss swing trading and investing in the company. We analyze the 55 EMA (Exponential Moving average), MACD (Moving Average Convergence Divergence), RSI (Relative Strength Index), bullish and bearish trends, technical analysis chart patterns, and potential entry and exit points for traders and investors.

👉USE FULL EXTENDED HOURS TRADING FOR FREE on WeBull App! (and get 2 free stocks worth up to $2300 when you deposit ONLY $5 into Webull)

Timecodes:
0:00 Intro
0:12 Fundamental Analysis
7:18 Technical Analysis

DISCLAIMER: I am not a financial advisor, and my opinions reflect mine only and no other entities. The ideas presented in this video are for entertainment purposes only and not intended as any financial advice, recommendations, suggestions, etc., despite what is stated. You (and only you) are responsible for the financial decisions that you make.

English is not my first language, so please excuse my mistakes. And If you like this video, please hit the like button. It helps me a lot!

#SAVA #SAVAstock #CassavaSciences